
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Quoin Pharmaceuticals Ltd | NASDAQ:QNRX | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0001 | -0.03% | 0.2994 | 0.2812 | 0.2994 | 0.3005 | 0.29 | 0.2905 | 333,983 | 21:39:43 |
Exhibit 99.1
Annex A
The Reporting Person currently has the following outstanding options pursuant to the Issuer’s equity plans:
Date
of option grant |
Number
of shares |
Exercise
Price Per Share |
Vesting Schedule | Expiration Date |
Portion
Vested at 12/23/2024 |
4/12/2022 | 7,143 | $210 | Vests in four equal annual installments beginning on April 12, 2023. | 04/12/2032 | 3,572 |
10/26/2023 | 80,965 | $5.75 | Vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027. | 10/26/2033 | 16,193 |
12/09/2024 | 536,603
|
$0.78 | Vests in four annual installments with 20% vesting on each of December 9, 2025, 2026 and 2027 and 40% vesting on December 9, 2028. | 12/09/2034 | __ |
The vesting of the unvested options described above will increase the Reporting Person's beneficial ownership of Ordinary Shares.
1 Year Quoin Pharmaceuticals Chart |
1 Month Quoin Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions